Keck Medicine of USC has launched a clinical trial to study the effect of a novel hormone replacement therapy on postmenopausal cardiovascular disease and cognitive decline.
Howard N. Hodis, MD, director of the USC Atherosclerosis Research Unit and an internal medicine specialist with Keck Medicine of USC, is the lead researcher of the study.